References
1. Vaduganathan M, Venkataramani AS, Bhatt DL. Moving Toward Global Primordial Prevention in Cardiovascular Disease: The Heart of the Matter J Am Coll Cardiol. 2015 Oct 6;66(14):1535-1537.
2. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults JAMA. 2012 Mar 28;307(12):1273-83.
3. Peñalvo JL, Santos-Beneit G, Sotos-Prieto M, Bodega P, Oliva B, Orrit X, Rodríguez C, Fernández-Alvira JM, Redondo J, Vedanthan R, Bansilal S, Gómez E, Fuster V. The SI! Program for Cardiovascular Health Promotion in Early Childhood: A Cluster-Randomized Trial J Am Coll Cardiol. 2015 Oct 6;66(14):1525-1534.
4. Dowd KP, Szeklicki R, Minetto MA, Murphy MH, Polito A, Ghigo E, van der Ploeg H, Ekelund U, Maciaszek J, Stemplewski R, Tomczak M, Donnelly AE. A systematic literature review of reviews on techniques for physical activity measurement in adults: a DEDIPAC study Int J Behav Nutr Phys Act. 2018 Feb 8;15(1):15. doi: 10.1186/s12966-017-0636-2.
5. Dhingra LS, Aminorroaya A, Oikonomou EK, Nargesi AA, Wilson FP, Krumholz HM, Khera R. Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020. JAMA Netw Open. 2023 Jun 1;6(6):e2316634. doi: 10.1001/jamanetworkopen.2023.16634.
6. Del Pozo Cruz B, Ahmadi MN, Lee IM, Stamatakis E. Prospective Associations of Daily Step Counts and Intensity With Cancer and Cardiovascular Disease JAMA Intern Med. 2022 Nov 1;182(11):1139-1148.
7. Stamatakis E, Ahmadi MN, Gill JMR, Thøgersen-Ntoumani C, Gibala MJ, Doherty A, Hamer M. Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality Nat Med. 2022 Dec;28(12):2521-2529.
8. Ahmadi MN, Hamer M, Gill JMR, Murphy M, Sanders JP, Doherty A, Stamatakis E. Brief bouts of device-measured intermittent lifestyle physical activity and its association with major adverse cardiovascular events and mortality in people who do not exercise: a prospective cohort study. Lancet Public Health. 2023 Oct;8(10):e800-e810. doi: 10.1016/S2468-2667(23)00183-4.
9. Stamatakis E, Ahmadi M, Biswas RK, Del Pozo Cruz B, Thøgersen-Ntoumani C, Murphy MH, Sabag A, Lear S, Chow C, Gill JMR, Hamer M. Device-measured vigorous intermittent lifestyle physical activity (VILPA) and major adverse cardiovascular events: evidence of sex differences Br J Sports Med. 2024 Dec 28:bjsports-2024-108484. doi: 10.1136/bjsports-2024-108484.
10. Stamatakis E, Ahmadi MN, Friedenreich CM, Blodgett JM, Koster A, Holtermann A, Atkin A, Rangul V, Sherar LB, Teixeira-Pinto A, Ekelund U, Lee IM, Hamer M. Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults: The UK Biobank Accelerometry Study. JAMA Oncol. 2023 Sep 1;9(9):1255-1259
Notes to editor
Note: The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.
